H.R.460 - Patients' Access to Treatments Act of 2013
To amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes.
One Moment Please
Loading Bill Text
Rollover any line of text to comment and/or link to it.
To amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes.CommentsClose CommentsPermalink
Mr. MCKINLEY (for himself, Mrs. CAPPS, Mrs. CAPITO, Mr. YOUNG of Florida, Mr. MORAN, Mr. WOLF, Mr. TONKO, Mr. RUNYAN, Mr. CONYERS, Ms. BONAMICI, Mr. CICILLINE, Mr. DEFAZIO, Mr. MICHAUD, Mr. FARR, Ms. PINGREE of Maine, Mr. RANGEL, and Mr. CRENSHAW) introduced the following bill; which was referred to the Committee on Energy and CommerceCommentsClose CommentsPermalink
To amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes.CommentsClose CommentsPermalink
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,CommentsClose CommentsPermalink
SEC. 2. COST-SHARING REQUIREMENTS APPLICABLE TO PRESCRIPTION DRUGS IN A SPECIALTY DRUG TIER.
(a) In General- Subpart II of part A of title XXVII of the Public Health Service Act (42 U.S.C. 300gg et seq.) is amended by adding at the end the following:CommentsClose CommentsPermalink
‘SEC. 2719B. COST-SHARING REQUIREMENTS APPLICABLE TO PRESCRIPTION DRUGS IN A SPECIALTY DRUG TIER.
‘(a) Requirement- A group health plan, or a health insurance issuer offering group or individual health insurance, that provides coverage for prescription drugs and uses a formulary or other tiered cost-sharing structure shall not impose cost-sharing requirements applicable to prescription drugs in a specialty drug tier that exceed the dollar amount (or its equivalent) of cost-sharing requirements applicable to prescription drugs in a non-preferred brand drug tier (or prescription drugs in a brand drug tier if there is no non-preferred brand drug tier).CommentsClose CommentsPermalink
‘(b) Special Rule- If a formulary used by a group health plan or a health insurance issuer offering group or individual health insurance contains more than one non-preferred brand drug tier, then the requirements of subsection (a) shall be applied with respect to the non-preferred brand drug tier for which beneficiary cost-sharing is lowest.CommentsClose CommentsPermalink
‘(2) The term ‘drug tier’ means, with respect to a group health plan or health insurance issuer offering group or individual health insurance coverage that uses a formulary or other cost-sharing structure, a category of drugs--CommentsClose CommentsPermalink
‘(A) within such formulary or structure for which the total dollar amount of cost-sharing requirements for any drug does not vary by more than ten percent from the total dollar amount of cost-sharing requirements for any other drug; andCommentsClose CommentsPermalink
‘(3) The term ‘non-preferred brand drug tier’ means, with respect to a group health plan or health insurance issuer offering group or individual health insurance coverage that uses a formulary or other tiered cost-sharing structure, a category of drugs--CommentsClose CommentsPermalink
‘(A) within a drug tier in such formulary or structure for which beneficiary cost-sharing is greater than drug tiers for generic drugs or preferred brand drugs in the formulary or structure;CommentsClose CommentsPermalink
‘(B) includes a drug described in subparagraph (A) that is a biological product (as defined in section 351(i) of this Act).CommentsClose CommentsPermalink
‘(5) The term ‘specialty drug tier’ means, with respect to a group health plan or health insurance issuer offering group or individual health insurance coverage that uses a formulary or other tiered cost-sharing structure, a category of drugs--CommentsClose CommentsPermalink
‘(A) within a drug tier in such formulary or structure for which beneficiary cost-sharing is greater than drug tiers for generic drugs, preferred brand drugs, or non-preferred drugs in the plan’s formulary; andCommentsClose CommentsPermalink
(b) Effective Date- Section 2719B of the Public Health Service Act, as added by subsection (a), applies to plan years beginning on or after the date of the enactment of this Act.CommentsClose CommentsPermalink
OpenCongress is a free and open-source project of the Participatory Politics Foundation, a 501(c)3 non-profit organization with a mission to increase civic engagement. The non-profit Sunlight Foundation is the Founding and Primary Supporter of OpenCongress.
U.S. Congress - Text of H.R.460 as Introduced in House Patients' Access to Treatments Act of 2013
